Home › Bronchiolitis Obliterans › Massachusetts
Bronchiolitis Obliterans clinical trials in Massachusetts
4 studies for Bronchiolitis Obliterans are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
RecruitingObservational study
Ages 7 and older · All sexes · Updated Jul 14, 2026 · NCT07434869TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Dana-Farber Cancer Institute/Boston Children's Hospital, Boston
RecruitingObservational study
Up to age 24 · All sexes · Updated Jun 22, 2026 · NCT04098445BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05922761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.